Stock 6901 DIAMOND BIOFUND INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Diamond Biofund Inc.

Equities

6901

TW0006901002

Investment Management & Fund Operators

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
39.7 TWD +2.19% Intraday chart for Diamond Biofund Inc. +2.06% -18.65%
May. 21 Diamond Biofund Inc. Approves Election of Directors of Board CI
May. 10 Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 48,069 41,446
Enterprise Value (EV) 1 37,335 31,928
P/E ratio 62 x -14.7 x
Yield 0.26% -
Capitalization / Revenue 47.3 x -17 x
EV / Revenue 36.8 x -13.1 x
EV / EBITDA 41.3 x -12.3 x
EV / FCF 69,863,396 x -18,767,481 x
FCF Yield 0% -0%
Price to Book 4.35 x 3.22 x
Nbr of stocks (in thousands) 749,300 849,300
Reference price 2 64.15 48.80
Announcement Date 3/24/23 2/29/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 -303.3 6,501 3,064 1,016 -2,440
EBITDA 1 -365.9 6,099 2,990 903.6 -2,597
EBIT 1 -367.8 6,097 2,988 902.2 -2,598
Operating Margin 121.25% 93.78% 97.52% 88.84% 106.48%
Earnings before Tax (EBT) 1 -370.8 6,091 2,961 881.1 -2,584
Net income 1 -370.9 6,090 2,852 797.8 -2,583
Net margin 122.27% 93.67% 93.08% 78.55% 105.9%
EPS 2 -0.5499 8.895 2.983 1.034 -3.320
Free Cash Flow - 3,931 1,963 534.4 -1,701
FCF margin - 60.46% 64.07% 52.62% 69.74%
FCF Conversion (EBITDA) - 64.45% 65.65% 59.14% -
FCF Conversion (Net income) - 64.55% 68.83% 66.99% -
Dividend per Share - 0.2002 0.2002 0.1695 -
Announcement Date 4/7/22 4/7/22 3/24/23 3/24/23 2/29/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 1,198 6,616 10,045 10,734 9,518
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - 3,931 1,963 534 -1,701
ROE (net income / shareholders' equity) - 101% 29.3% 7.44% -21.6%
ROA (Net income/ Total Assets) - 61.8% 18.8% 5.17% -13.4%
Assets 1 - 9,857 15,180 15,433 19,284
Book Value Per Share 2 4.460 13.50 11.40 14.70 15.10
Cash Flow per Share 2 0.6200 0.0400 0.0200 0.4500 2.470
Capex 1 1.25 - - 1.46 19.1
Capex / Sales -0.41% - - 0.14% -0.78%
Announcement Date 4/7/22 4/7/22 3/24/23 3/24/23 2/29/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Investment Management & Fund Operators

1st Jan change Capi.
DIAMOND BIOFUND INC. Stock Diamond Biofund Inc.
-18.65% 1.04B
BLACKROCK, INC. Stock BlackRock, Inc.
-4.90% 115B
UBS GROUP AG Stock UBS Group AG
+9.16% 101B
BROOKFIELD CORPORATION Stock Brookfield Corporation
+11.67% 67.41B
APOLLO GLOBAL MANAGEMENT, INC. Stock Apollo Global Management, Inc.
+24.65% 66.1B
BANK OF NEW YORK MELLON CORPORATION (THE) Stock Bank of New York Mellon Corporation (The)
+14.52% 44.58B
AMERIPRISE FINANCIAL, INC. Stock Ameriprise Financial, Inc.
+14.85% 43.37B
3I GROUP PLC Stock 3i Group plc
+18.26% 35.13B
T. ROWE PRICE GROUP INC. Stock T. Rowe Price Group Inc.
+9.42% 26.31B
STATE STREET CORPORATION Stock State Street Corporation
-2.41% 22.77B
Other Investment Management & Fund Operators
  1. Stock Market
  2. Equities
  3. 6901 Stock
  4. Financials Diamond Biofund Inc.